Innovate in care and research in dermatology
The fondation
Our mission is to improve the quality of care by developing international actions bringing together dermatologists, researchers, the pharmaceutical and cosmetics industry and health authorities.
Our actions are aimed in particular at improving the management of patients with rare skin diseases or chronic inflammatory skin diseases: continuing education, prevention, treatment, research, and networking.
Our activities
Treating chronic inflammatory skin diseases. Chronic inflammatory skin diseases affect 2-4% of the world's population.
Treating rare skin diseases. There are more than 600 rare skin diseases. In Europe, a disease is said to be rare when it affects 1 person in 2000.
Train healthcare professionals. A network of experts regularly updates the first online therapeutic book available free of charge and dedicated to the treatment of skin diseases.
Support research to find new treatments. A network promoting therapeutic progress by helping to develop international research collaborations.
Support the foundation – Make a donation
The skin is an organ of relationship, your skin is your image. The skin is the first organ affected by poverty. Skin diseases cause social exclusion. Show your solidarity by becoming a partner.
Our expertise
TRAIN
Develop the training of healthcare professionals, researchers, students.
GATHER
Support international collaborations between dermatologists, researchers, pharmaceutical and cosmetics industry, health authorities, around the unmet needs of patients.
INNOVATE
Supporting research to find new treatments and improve the early diagnosis of skin diseases.
CARE
Improve access to care for patients with rare skin diseases or chronic inflammatory skin diseases.
Global participation and collaboration
Disseminating information and sharing knowledge
Training and education of professionals
News
The Fondation René Touraine (FRT) is a European non-governmental, non-profit organization. The purpose of the Fondation René Touraine is to support therapeutic progress in dermatology through actions bringing together dermatologists, scientists, pharmaceutical companies and health authorities.
